Former U.S. women’s soccer star Abby Wambach intends to fully divest from a concussion drug company that is backed by Brett Favre. The company is at the center of a Mississippi welfare fraud case involving the former NFL quarterback, she told ESPN in an email this week.
Wambach, a World Cup winner and two-time gold medalist with the USWNT, was a member of the sports advisory board for Odyssey Health, a drug company that has said it is developing a nasal spray to treat concussions. Favre is Odyssey Health’s top investor.
According to a lawsuit filed by the state of Mississippi, $2.1 million that was supposed to be given to welfare recipients was instead directed toward Odyssey Health. The company, previously known as Prevacus, was connected to the fraud case when arrests were first made in 2020, as reported by Anna Wolfe of Mississippi Today.
